top of page
QMT
Designed for clinical and medical use
Available in 2 models
M2101 : FDA-cleared for clinical use in the U.S.
M2101S : HSA-registered for use in Singapore

Optimised
Signal
Generation

Precision
Muscle
Targeting
Design

Versatile Field Applicator for Bed-top use

Ergonomic Tilt Feature in Seated Position

Who it’s for
-
Hospitals, physiotherapy clinics, rehabilitation centres, post-op recovery wards.
-
Patients needing safe and gentle, non-exertive rehabilitation modalities


How it works
QMT uses gentle, low-frequency electromagnetic signals to activate deep muscle tissue without requiring physical effort from the user. When applied to the body, it stimulates mitochondria to strengthen muscles, prevent sarcopenia, and support recovery.
Engineered for flexibility and precision, QMT features optimised signal generation, precision muscle targeting design, and a versatile field applicator for use directly on beds or chairs. Its ergonomic tilt feature also ensures comfort and effectiveness in seated positions — making it highly adaptable for clinical, rehab, or bedside settings.
Read More
Key Benefits
Helps reduce Muscle Weakness & Atrophy
Supports faster Post-Surgical & Post-Injury Rehabilitation
Improves Osteoarthritis & Joint Pain Management
Enhances Stroke & Neurological Rehabilitation outcomes

Clinical Results
Backed by rigorous clinical trials, MitoCharge Technology has shown measurable improvements in both recovery and function. In elderly users, 85% experienced improved mobility, balance, and sit-to-stand ability after just 12 weeks. Patients with osteoarthritis saw a +17% increase in knee strength compared to controls, along with a 60% greater reduction in pain scores. These outcomes highlight QMT’s ability to deliver safe, non-invasive muscle activation with meaningful, lasting results.
Read More
85%
of frail elderly improve mobility & balance
After 12 weeks
+17%
Gains For OA patients' strength with MitoCharge & Exercise
vs. 1% gain with exercise only
60%
More Pain Reduction
vs. exercise only group
*Wang et al., Frontiers in Medicine, 2024
*Venugobal et al., Aging (Albany NY), 2023
bottom of page